Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ISRG's Cash to Debt is ranked higher than
96% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. ISRG: No Debt )
Ranked among companies with meaningful Cash to Debt only.
ISRG' s Cash to Debt Range Over the Past 10 Years
Min: 12.85  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.88
ISRG's Equity to Asset is ranked higher than
89% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. ISRG: 0.88 )
Ranked among companies with meaningful Equity to Asset only.
ISRG' s Equity to Asset Range Over the Past 10 Years
Min: 0.7  Med: 0.87 Max: 0.9
Current: 0.88
0.7
0.9
Interest Coverage No Debt
ISRG's Interest Coverage is ranked higher than
93% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 481.81 vs. ISRG: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ISRG' s Interest Coverage Range Over the Past 10 Years
Min: 4045.41  Med: 10000.00 Max: 9999.99
Current: No Debt
4045.41
9999.99
F-Score: 7
Z-Score: 22.45
M-Score: -2.31
WACC vs ROIC
3.18%
24.48%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 31.04
ISRG's Operating margin (%) is ranked higher than
97% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. ISRG: 31.04 )
Ranked among companies with meaningful Operating margin (%) only.
ISRG' s Operating margin (%) Range Over the Past 10 Years
Min: 25.56  Med: 35.70 Max: 40.3
Current: 31.04
25.56
40.3
Net-margin (%) 24.69
ISRG's Net-margin (%) is ranked higher than
95% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. ISRG: 24.69 )
Ranked among companies with meaningful Net-margin (%) only.
ISRG' s Net-margin (%) Range Over the Past 10 Years
Min: 19.33  Med: 25.54 Max: 41.41
Current: 24.69
19.33
41.41
ROE (%) 15.34
ISRG's ROE (%) is ranked higher than
82% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. ISRG: 15.34 )
Ranked among companies with meaningful ROE (%) only.
ISRG' s ROE (%) Range Over the Past 10 Years
Min: 12.17  Med: 19.26 Max: 24.85
Current: 15.34
12.17
24.85
ROA (%) 13.36
ISRG's ROA (%) is ranked higher than
91% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -0.07 vs. ISRG: 13.36 )
Ranked among companies with meaningful ROA (%) only.
ISRG' s ROA (%) Range Over the Past 10 Years
Min: 10.59  Med: 16.83 Max: 22
Current: 13.36
10.59
22
ROC (Joel Greenblatt) (%) 135.53
ISRG's ROC (Joel Greenblatt) (%) is ranked higher than
97% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. ISRG: 135.53 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ISRG' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 114.4  Med: 186.03 Max: 245.9
Current: 135.53
114.4
245.9
Revenue Growth (3Y)(%) 9.00
ISRG's Revenue Growth (3Y)(%) is ranked higher than
71% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. ISRG: 9.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ISRG' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 22.80 Max: 57.1
Current: 9
0
57.1
EBITDA Growth (3Y)(%) -3.80
ISRG's EBITDA Growth (3Y)(%) is ranked lower than
59% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. ISRG: -3.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ISRG' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -62.7  Med: 29.90 Max: 321.3
Current: -3.8
-62.7
321.3
EPS Growth (3Y)(%) -3.40
ISRG's EPS Growth (3Y)(%) is ranked lower than
58% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. ISRG: -3.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ISRG' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -61.4  Med: 26.80 Max: 76.7
Current: -3.4
-61.4
76.7
» ISRG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

ISRG Guru Trades in Q1 2015

Jim Simons 228,270 sh (+206.40%)
John Hussman 10,000 sh (+100.00%)
John Burbank 4,938 sh (+21.57%)
Vanguard Health Care Fund 414,400 sh (unchged)
Robert Olstein 11,000 sh (unchged)
Paul Tudor Jones Sold Out
Ray Dalio Sold Out
Joel Greenblatt 6,762 sh (-0.56%)
Jeremy Grantham 155,911 sh (-3.25%)
Manning & Napier Advisors, Inc 144,950 sh (-4.82%)
Steven Cohen 62,500 sh (-5.59%)
RS Investment Management 38,304 sh (-61.12%)
» More
Q2 2015

ISRG Guru Trades in Q2 2015

Ray Dalio 5,039 sh (New)
John Hussman 15,000 sh (+50.00%)
Robert Olstein 12,000 sh (+9.09%)
Manning & Napier Advisors, Inc 154,975 sh (+6.92%)
Vanguard Health Care Fund 414,400 sh (unchged)
John Burbank Sold Out
Joel Greenblatt Sold Out
RS Investment Management 35,505 sh (-7.31%)
Jeremy Grantham 133,965 sh (-14.08%)
Jim Simons 127,039 sh (-44.35%)
Steven Cohen 15,000 sh (-76.00%)
» More
Q3 2015

ISRG Guru Trades in Q3 2015

Joel Greenblatt 4,128 sh (New)
George Soros 1,100 sh (New)
Manning & Napier Advisors, Inc 595,225 sh (+284.08%)
Jim Simons 202,596 sh (+59.48%)
Ray Dalio 7,824 sh (+55.27%)
Vanguard Health Care Fund 440,200 sh (+6.23%)
Robert Olstein 12,500 sh (+4.17%)
John Hussman 15,000 sh (unchged)
RS Investment Management Sold Out
Jeremy Grantham 85,811 sh (-35.95%)
Steven Cohen 8,200 sh (-45.33%)
» More
Q4 2015

ISRG Guru Trades in Q4 2015

Vanguard Health Care Fund 519,996 sh (+18.13%)
John Hussman Sold Out
Robert Olstein 11,000 sh (-12.00%)
Jim Simons 109,170 sh (-46.11%)
Ray Dalio 2,024 sh (-74.13%)
» More
» Details

Insider Trades

Latest Guru Trades with ISRG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Intuitive Surgical Inc

Baron Funds Comments on Intuitive Surgical - May 05, 2014

We sold out of the last of long-term holding Intuitive Surgical, Inc. (NASDAQ:ISRG) Intuitive was one of the great investments in the Fund's history, but we let go of the last remnants of our position as the stock rebounded, and we felt uncertain about the device's utility in some of its new general surgery applications. Intuitive also has a $16 billion market cap on sale (it was $350 million on purchase!), and we need to be cognizant of market cap in our portfolio construction.





From Baron Funds' first quarter 2014 commentary.



Check out Ron Baron latest stock trades

Top Ranked Articles about Intuitive Surgical Inc

Weekly Insider Sells Highlights: Nike, Intuitive Surgical, Travelers Companies, Stryker A summary of last week's insider activity
According to GuruFocus Insider Data, the largest insider sells during the past week were: Nike Inc. (NYSE:NKE), Intuitive Surgical Inc. (NASDAQ:ISRG), Travelers Companies Inc. (NYSE:TRV) and Stryker Corporation (NYSE:SYK). Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 36.12
ISRG's P/E(ttm) is ranked lower than
66% of the 250 Companies
in the Global Medical Devices industry.

( Industry Median: 27.86 vs. ISRG: 36.12 )
Ranked among companies with meaningful P/E(ttm) only.
ISRG' s P/E(ttm) Range Over the Past 10 Years
Min: 17.77  Med: 39.10 Max: 107.2
Current: 36.12
17.77
107.2
Forward P/E 25.71
ISRG's Forward P/E is ranked lower than
71% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 18.66 vs. ISRG: 25.71 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 36.12
ISRG's PE(NRI) is ranked lower than
66% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 28.10 vs. ISRG: 36.12 )
Ranked among companies with meaningful PE(NRI) only.
ISRG' s PE(NRI) Range Over the Past 10 Years
Min: 17.8  Med: 39.12 Max: 107.2
Current: 36.12
17.8
107.2
P/B 4.51
ISRG's P/B is ranked lower than
82% of the 385 Companies
in the Global Medical Devices industry.

( Industry Median: 2.63 vs. ISRG: 4.51 )
Ranked among companies with meaningful P/B only.
ISRG' s P/B Range Over the Past 10 Years
Min: 2.81  Med: 6.25 Max: 15.72
Current: 4.51
2.81
15.72
P/S 8.29
ISRG's P/S is ranked lower than
99% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 2.24 vs. ISRG: 8.29 )
Ranked among companies with meaningful P/S only.
ISRG' s P/S Range Over the Past 10 Years
Min: 4.16  Med: 9.94 Max: 24.27
Current: 8.29
4.16
24.27
PFCF 35.46
ISRG's PFCF is ranked lower than
59% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: 32.78 vs. ISRG: 35.46 )
Ranked among companies with meaningful PFCF only.
ISRG' s PFCF Range Over the Past 10 Years
Min: 18.44  Med: 34.36 Max: 128.24
Current: 35.46
18.44
128.24
POCF 28.89
ISRG's POCF is ranked lower than
68% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 19.65 vs. ISRG: 28.89 )
Ranked among companies with meaningful POCF only.
ISRG' s POCF Range Over the Past 10 Years
Min: 11.34  Med: 28.77 Max: 84.6
Current: 28.89
11.34
84.6
EV-to-EBIT 26.34
ISRG's EV-to-EBIT is ranked lower than
60% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 24.07 vs. ISRG: 26.34 )
Ranked among companies with meaningful EV-to-EBIT only.
ISRG' s EV-to-EBIT Range Over the Past 10 Years
Min: 10.2  Med: 27.65 Max: 74.4
Current: 26.34
10.2
74.4
EV-to-EBITDA 23.39
ISRG's EV-to-EBITDA is ranked lower than
65% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 17.52 vs. ISRG: 23.39 )
Ranked among companies with meaningful EV-to-EBITDA only.
ISRG' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.5  Med: 24.80 Max: 63.8
Current: 23.39
9.5
63.8
PEG 3.21
ISRG's PEG is ranked higher than
53% of the 68 Companies
in the Global Medical Devices industry.

( Industry Median: 3.39 vs. ISRG: 3.21 )
Ranked among companies with meaningful PEG only.
ISRG' s PEG Range Over the Past 10 Years
Min: 0.14  Med: 0.85 Max: 17.32
Current: 3.21
0.14
17.32
Shiller P/E 52.67
ISRG's Shiller P/E is ranked lower than
70% of the 64 Companies
in the Global Medical Devices industry.

( Industry Median: 32.91 vs. ISRG: 52.67 )
Ranked among companies with meaningful Shiller P/E only.
ISRG' s Shiller P/E Range Over the Past 10 Years
Min: 44.24  Med: 94.41 Max: 244.46
Current: 52.67
44.24
244.46
Current Ratio 5.01
ISRG's Current Ratio is ranked higher than
76% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.66 vs. ISRG: 5.01 )
Ranked among companies with meaningful Current Ratio only.
ISRG' s Current Ratio Range Over the Past 10 Years
Min: 2.07  Med: 4.63 Max: 7.43
Current: 5.01
2.07
7.43
Quick Ratio 4.61
ISRG's Quick Ratio is ranked higher than
78% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. ISRG: 4.61 )
Ranked among companies with meaningful Quick Ratio only.
ISRG' s Quick Ratio Range Over the Past 10 Years
Min: 1.72  Med: 4.30 Max: 7.07
Current: 4.61
1.72
7.07
Days Inventory 85.74
ISRG's Days Inventory is ranked higher than
75% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 142.23 vs. ISRG: 85.74 )
Ranked among companies with meaningful Days Inventory only.
ISRG' s Days Inventory Range Over the Past 10 Years
Min: 52.29  Med: 69.46 Max: 91.85
Current: 85.74
52.29
91.85
Days Sales Outstanding 60.36
ISRG's Days Sales Outstanding is ranked higher than
64% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 72.25 vs. ISRG: 60.36 )
Ranked among companies with meaningful Days Sales Outstanding only.
ISRG' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.57  Med: 67.36 Max: 92.73
Current: 60.36
48.57
92.73
Days Payable 23.81
ISRG's Days Payable is ranked lower than
86% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 59.85 vs. ISRG: 23.81 )
Ranked among companies with meaningful Days Payable only.
ISRG' s Days Payable Range Over the Past 10 Years
Min: 25.13  Med: 33.70 Max: 58.29
Current: 23.81
25.13
58.29

Valuation & Return

vs
industry
vs
history
Price/Net Cash 20.07
ISRG's Price/Net Cash is ranked lower than
59% of the 143 Companies
in the Global Medical Devices industry.

( Industry Median: 12.35 vs. ISRG: 20.07 )
Ranked among companies with meaningful Price/Net Cash only.
ISRG' s Price/Net Cash Range Over the Past 10 Years
Min: 2.88  Med: 22.32 Max: 333.4
Current: 20.07
2.88
333.4
Price/Net Current Asset Value 12.13
ISRG's Price/Net Current Asset Value is ranked lower than
70% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: 9.50 vs. ISRG: 12.13 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ISRG' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 2.21  Med: 11.91 Max: 28.5
Current: 12.13
2.21
28.5
Price/Tangible Book 4.79
ISRG's Price/Tangible Book is ranked lower than
55% of the 362 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. ISRG: 4.79 )
Ranked among companies with meaningful Price/Tangible Book only.
ISRG' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.05  Med: 6.11 Max: 16.47
Current: 4.79
2.05
16.47
Price/Projected FCF 1.79
ISRG's Price/Projected FCF is ranked lower than
59% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 1.94 vs. ISRG: 1.79 )
Ranked among companies with meaningful Price/Projected FCF only.
ISRG' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.93  Med: 3.50 Max: 13.91
Current: 1.79
1.93
13.91
Price/DCF (Earnings Based) 1.18
ISRG's Price/DCF (Earnings Based) is ranked higher than
71% of the 35 Companies
in the Global Medical Devices industry.

( Industry Median: 1.82 vs. ISRG: 1.18 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.86
ISRG's Price/Median PS Value is ranked higher than
64% of the 374 Companies
in the Global Medical Devices industry.

( Industry Median: 0.99 vs. ISRG: 0.86 )
Ranked among companies with meaningful Price/Median PS Value only.
ISRG' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.31  Med: 0.89 Max: 2.25
Current: 0.86
0.31
2.25
Price/Graham Number 2.68
ISRG's Price/Graham Number is ranked lower than
54% of the 248 Companies
in the Global Medical Devices industry.

( Industry Median: 2.73 vs. ISRG: 2.68 )
Ranked among companies with meaningful Price/Graham Number only.
ISRG' s Price/Graham Number Range Over the Past 10 Years
Min: 1.81  Med: 3.61 Max: 8
Current: 2.68
1.81
8
Earnings Yield (Greenblatt) (%) 3.83
ISRG's Earnings Yield (Greenblatt) (%) is ranked higher than
62% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. ISRG: 3.83 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ISRG' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.3  Med: 3.60 Max: 9.8
Current: 3.83
1.3
9.8
Forward Rate of Return (Yacktman) (%) 6.83
ISRG's Forward Rate of Return (Yacktman) (%) is ranked lower than
51% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 5.28 vs. ISRG: 6.83 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ISRG' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -1.1  Med: 31.25 Max: 141.9
Current: 6.83
-1.1
141.9

More Statistics

Revenue(Mil) $2384
EPS $ 14.49
Beta0.19
Short Percentage of Float4.71%
52-Week Range $447.00 - 580.00
Shares Outstanding(Mil)37.37

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 2,632 2,964 3,244
EPS($) 19.36 20.30 22.53
EPS without NRI($) 19.36 20.30 22.53

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Devices » Medical Devices
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:IUI1.Germany, ISRG.Switzerland, 0R29.UK,
Intuitive Surgical Inc is a Delaware corporation founded in 1995. The Company designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories. A da Vinci Surgical System consists of a surgeon's console, a patient-side cart, and a high performance vision system. da Vinci Surgery utilizes computational, robotic and imaging technologies to enable improved patient outcomes compared to other surgical and non-surgical therapies. The Company has commercialized four generations of da Vinci Surgical System- the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. da Vinci Surgical Systems are comprised of the following components: Surgeon's Console. The da Vinci Surgical System allows surgeons to operate while comfortably seated at an ergonomic console viewing a 3-D image of the surgical field. Patient-Side Cart. The patient-side cart holds electromechanical arms that manipulate the instruments inside the patient. 3-D Vision System. Its vision system includes its InSite 3-D endoscope with two separate vision channels linked to two separate color monitors through high performance video cameras and specialized image processing hardware. da Vinci Skills Simulator. The Skills Simulator is a practice tool that gives a user the opportunity to practice his or her facility with the surgeon console controls. EndoWrist instruments are offered in a variety of sizes, of which 5mm and 8mm diameter sizes are commonly sold. The Company provides its products through a direct sales organization in the U.S, mainly of Western Europe excluding Spain, Portugal, Italy and Greece; Japan and Korea. The Company's products and operations are subject to rigorous regulation by the FDA, the State of California and countries or regions in which the company markets its products.
» More Articles for ISRG

Headlines

Articles On GuruFocus.com
The 2016 Nintai Charitable Trust Portfolio: Annual Review Jan 18 2016 
Getting to Zero: Value and Risk Management Dec 04 2015 
Weekly Insider Sells Highlights: Nike, Intuitive Surgical, Travelers Companies, Stryker Oct 26 2015 
Guru Stocks at 52-Week Lows: Walmart, VMWare, Intuitive Surgical, Macy's, Nordstrom Oct 16 2015 
Weekly CFO Sells Highlight: GoPro Inc, Fortinet Inc, and Intuitive Surgical Inc. Aug 04 2015 
Weekly Insider Sells Highlight: ZION, PYPL, FTNT, ISRG Aug 02 2015 
Margin of Safety: How Much is Enough? Jun 08 2015 
A Purchase and a Sale at Nintai Jun 03 2015 
Weekly CFO Sells Highlight: Google Inc, Bank of New York Mellon Corp, and Intuitive Surgical Inc. May 03 2015 
Google Set To Bring In A Difference In The World Of Surgery Mar 30 2015 

More From Other Websites
Is Intuitive Surgical (ISRG) Stock a Solid Choice Right Now? Feb 11 2016
Intuitive Surgical Reports New Employee Option Grants for February 2016 Feb 09 2016
Intuitive Surgical, Inc. breached its 50 day moving average in a Bearish Manner : February 8, 2016 Feb 08 2016
INTUITIVE SURGICAL INC Financials Feb 06 2016
Nike To Facebook: Frank Caruso Projects Long-Term Earnings Growth Feb 05 2016
Intuitive Surgical Making A Comeback As Robotic Surgery Gains Ground Feb 03 2016
3 Stocks to Profit From the Rise of Robotics Feb 03 2016
INTUITIVE SURGICAL INC Files SEC form 10-K, Annual Report Feb 02 2016
Keith R. Leonard, Jr. Appointed to Intuitive Surgical Board of Directors Feb 01 2016
INTUITIVE SURGICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Feb 01 2016
Keith R. Leonard, Jr. Appointed to Intuitive Surgical Board of Directors Feb 01 2016
3 Health Care Stocks to Own in a Dangerous Market Jan 29 2016
Intuitive Surgical, Inc. – Value Analysis (NASDAQ:ISRG) : January 28, 2016 Jan 28 2016
Intuitive Surgical, Inc. breached its 50 day moving average in a Bearish Manner : January 28, 2016 Jan 28 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK